Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China ...Middle East

PR Newswire - News
Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China
SAINT-CLOUD, France, June 13, 2024 /PRNewswire/ -- Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate, Shanghai Ethypharm Pharmaceuticals Ltd, from the Chinese Company Jiangsu Anbison Pharmaceutical. Leader in essential medicines...

Hence then, the article about ethypharm expands its mesalazine etiasa portfolio in china was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ethypharm expands its Mesalazine (Etiasa®) Portfolio in China )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News